Immune Allergy Transplant
Build practical clinical judgment in immune allergy transplant through clear visual lessons created for international nursing learners and teaching discussions.
55 presentation slides and a matching infographic.
Lesson text and sources
Read alongside the visual presentation. Expand a lesson to review its text, teaching explanation and references.
1. Immune, Allergy & Transplant
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 01 / 55 RN Clarity C03 • SYSTEM Immune, Allergy & Transplant Clinical judgment for international nursing learners Independent NCLEX-RN® preparation • USA + Canada
Teaching explanation
This lesson covers immune function, anaphylaxis, transfusion reactions, immunosuppression and transplant surveillance. Kidney transplantation is the detailed transplant example; other organs have different monitoring plans. Cases and questions are original fictional teaching exercises, not patient records or official examination items. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAID • Overview of the Immune System
- Locator: Immune function; February 2026
- https://www.niaid.nih.gov/research/immune-system-overview
2. When immune defence becomes harmful
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 02 / 55 RN Clarity When immune defence becomes harmful Defence can be too weak, excessive or misdirected. Recognize new threats to breathing, circulation and organ function. Connect the patient’s symptoms with exposures and treatment.
Teaching explanation
The same symptom can have different explanations. Fever may accompany infection or inflammation; breathlessness may reflect a reaction or another disease. Clinical judgment combines the pattern, time course and patient context instead of assuming that an immune diagnosis explains every new finding. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAID • Overview of the Immune System
- Locator: Immune function; February 2026
- https://www.niaid.nih.gov/research/immune-system-overview
3. Connect barriers, defence and memory
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 03 / 55 RN Clarity Connect barriers, defence and memory 01 Skin and mucosal barriers reduce entry of pathogens. 02 Innate responses act rapidly against threats. 03 Adaptive responses provide targeted recognition and memory. Sources: RESP · Details and public links in notes
Teaching explanation
Innate and adaptive immunity work together rather than as separate systems. Damage to barriers, reduced immune-cell function or immunosuppressive medicines can increase vulnerability. The simplified sequence is an explanatory model, not a timeline that predicts exactly when a particular patient becomes ill. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAID • Features of an Immune Response
- Locator: Innate and adaptive responses
- https://www.niaid.nih.gov/research/immune-response-features
4. Translate the immune terms used on the floor
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 04 / 55 RN Clarity Translate the immune terms used on the floor 01 Antigen = a substance recognized by the immune system. 02 Immunosuppression = reduced immune activity, often due to treatment. 03 ANC = absolute neutrophil count, a specific infection-risk measure.
Teaching explanation
Neutrophils are a type of white blood cell. A total white-cell count and the absolute neutrophil count are not interchangeable. Ask the learner to explain the terms without implying that one laboratory value captures all immune function or all infection risk. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAID • Overview of the Immune System
- Locator: Immune function; February 2026
- https://www.niaid.nih.gov/research/immune-system-overview
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
5. Build an exposure and treatment timeline
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 05 / 55 RN Clarity Build an exposure and treatment timeline 01 Ask about new medicines, foods, infusions and symptoms. 02 Record the reaction description and time of onset. 03 Review immune therapy, recent treatment and usual organ function. Sources: ALL • TX · Details and public links in notes
Teaching explanation
A timeline makes associations visible but does not prove causation. Ask what actually occurred rather than copying an unverified allergy label. For transplant recipients, include medication access, missed doses and recent illness. Communicate uncertain information as uncertain so the team can clarify it. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
6. Link the symptom with the mechanism
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 06 / 55 RN Clarity Link the symptom with the mechanism 01 Mediator release can affect airway, vessels and skin. 02 Immune injury can damage the body’s own tissues. 03 Suppressed defences can make infection harder to recognize. Sources: ANA • LUPUS • NCI · Details and public links in notes
Teaching explanation
These mechanisms help learners connect findings rather than memorize disconnected lists. Multiple mechanisms may coexist, such as autoimmune disease treated with immunosuppression during an infection. The bedside priority is the patient’s current threat, not selecting one category prematurely. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
7. Investigations support the clinical assessment
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 07 / 55 RN Clarity Investigations support the clinical assessment 01 A blood count describes cell numbers, not all immune function. 02 Cultures investigate infection; interpretation needs clinical context. 03 Organ-function trends help assess injury or graft dysfunction. Sources: NCI • TX · Details and public links in notes
Teaching explanation
Tests answer specific questions. A reassuring result does not erase a concerning change in breathing or circulation. Conversely, an abnormal result requires interpretation rather than automatic treatment. The clinical team determines which investigations are indicated and how they alter the plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
8. Clarify what an “allergy” entry means
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 08 / 55 RN Clarity Clarify what an “allergy” entry means 01 Ask which substance caused the problem. 02 Describe the symptoms, timing and treatment received. 03 Escalate uncertainty before the next relevant exposure. Sources: ALL • TEAM · Details and public links in notes
Teaching explanation
Record the patient’s description faithfully and distinguish it from a confirmed diagnosis. An adverse effect and an allergy are not the same thing, but the nurse should not delete an allergy label casually. The responsible clinician or allergy service can clarify the diagnosis and future avoidance plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
9. Anaphylaxis is a rapidly evolving emergency
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 09 / 55 RN Clarity Anaphylaxis is a rapidly evolving emergency 01 Airway, breathing or circulatory compromise may develop quickly. 02 Skin symptoms can occur, but their absence does not exclude it. 03 Treat a concerning clinical pattern without waiting for every sign. Sources: ANA · Details and public links in notes
Teaching explanation
Anaphylaxis can involve several organ systems after an exposure. Recognition is clinical and time-sensitive. A patient with a new airway or circulatory problem needs immediate assessment even without hives. Do not delay an emergency response while trying to complete a textbook symptom checklist. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
10. Epinephrine is central to emergency treatment
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 10 / 55 RN Clarity Epinephrine is central to emergency treatment 01 Activate emergency help and assess airway, breathing and circulation. 02 Give indicated epinephrine through the authorized emergency pathway. 03 Support breathing and circulation; reassess the response. Sources: ANA · Details and public links in notes
Teaching explanation
Emergency Care BC describes early intramuscular epinephrine in emergency treatment. Dose, formulation, repeat treatment and additional measures follow the current patient-specific protocol. IV epinephrine is a specialist monitored intervention, not a substitute for the usual initial route. This deck does not provide a dosing algorithm. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
11. Do not substitute symptom relief for rescue
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 11 / 55 RN Clarity Do not substitute symptom relief for rescue 01 Antihistamines may improve skin symptoms. 02 They do not replace epinephrine for anaphylaxis. 03 The prescribed rescue product and instructions must be clear.
Teaching explanation
Different epinephrine delivery products exist, and availability and indications differ by jurisdiction. Community teaching should use the person’s prescribed device and current instructions. Avoid teaching that an antihistamine can prevent progression of a serious reaction or that an improvement in hives proves respiratory safety. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
12. Case 1: no rash, but her voice has changed
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 12 / 55 RN Clarity Case 1: no rash, but her voice has changed FICTIONAL BEDSIDE SCENARIO 01 During a new infusion, Sara reports throat tightness. 02 Her voice changes and she becomes breathless and faint. 03 A colleague says an allergic emergency should always have hives. Sources: ANA · Details and public links in notes
Teaching explanation
Fictional case. The absence of a rash is not a safe reason to delay. Stop the suspected exposure through the applicable infusion response process, activate urgent help and support the authorized anaphylaxis plan. Ask learners to identify the immediate threats and the misleading assumption. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
13. Case 1: communicate the time link and threat
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 13 / 55 RN Clarity Case 1: communicate the time link and threat “Her voice and breathing changed during the infusion.” “She reports throat tightness and now feels faint.” “Emergency help is needed for a possible severe reaction.” Sources: ANA • TEAM · Details and public links in notes
Teaching explanation
This original dialogue reports the association without declaring a confirmed allergen. Add the actual infusion, timing and measured observations when available. The emergency response and bedside support should proceed without waiting for a long documentation task. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
14. Case 1: improvement still needs a follow-up plan
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 14 / 55 RN Clarity Case 1: improvement still needs a follow-up plan 01 Continue the prescribed observation for recurrent symptoms. 02 Document the exposure, signs, treatment and response. 03 Confirm rescue education and allergy follow-up before discharge. Sources: ANA • ALL · Details and public links in notes
Teaching explanation
Recurrent symptoms can occur after initial improvement. Observation duration depends on the clinical course and risk assessment; do not teach one fixed time for every patient. The final allergy and discharge plan should identify what is known, what remains uncertain and how to obtain help. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
15. A transfusion reaction can have several causes
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 15 / 55 RN Clarity A transfusion reaction can have several causes 01 New fever, rigors, pain or dyspnea needs assessment. 02 Hemolysis, infection and pulmonary complications can overlap. 03 Do not assume a new reaction is harmless because it looks familiar. Sources: BLOOD · Details and public links in notes
Teaching explanation
Transfusion reactions can be acute or delayed. A symptom is not enough to establish the reaction type. The bedside nurse’s first job is to recognize the change and use the local transfusion reaction process. The transfusion service and clinical team investigate the cause. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
16. Respond promptly to a serious reaction
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 16 / 55 RN Clarity Respond promptly to a serious reaction 01 Stop the transfusion and assess the patient. 02 Notify the responsible clinician and transfusion service. 03 Maintain safe access and follow the investigation instructions. Sources: BLOOD · Details and public links in notes
Teaching explanation
Use the organization’s procedure for IV access, samples, product handling and reporting. Do not discard the implicated product or improvise a restart decision. Serious breathing or circulatory compromise requires the emergency response as well as transfusion-service notification. Treatment depends on the suspected cause. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
17. Distinguish overload from acute lung injury
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 17 / 55 RN Clarity Distinguish overload from acute lung injury 01 TACO = transfusion-associated circulatory overload. 02 TRALI = transfusion-related acute lung injury. 03 Both can cause breathing problems, but treatment is not identical.
Teaching explanation
TACO involves circulatory overload; TRALI involves non-cardiogenic pulmonary edema and respiratory failure. The team uses the clinical course, fluid status and investigations to differentiate causes. Do not prescribe a diuretic merely because any transfusion-associated breathlessness occurs. Recognize and escalate first. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
18. Case 2: rigors begin during blood administration
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 18 / 55 RN Clarity Case 2: rigors begin during blood administration FICTIONAL BEDSIDE SCENARIO 01 Omar develops shaking chills during a red-cell transfusion. 02 He reports new back discomfort and feels unwell. 03 The infusion is still running when the nurse reaches the bedside. Sources: BLOOD · Details and public links in notes
Teaching explanation
Fictional case. The appropriate response is to stop the transfusion and assess while notifying the relevant team. A severe reaction cannot be ruled out by assuming the patient is simply cold. Ask which information and materials will be needed for the local reaction investigation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
19. Case 2: describe the change and current action
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 19 / 55 RN Clarity Case 2: describe the change and current action “He developed rigors and new back discomfort during transfusion.” “The transfusion is stopped and I am assessing him.” “Please initiate the reaction assessment and investigation plan.” Sources: BLOOD • TEAM · Details and public links in notes
Teaching explanation
The statement identifies the product exposure and immediate action. Add current observations and any signs of instability. It does not diagnose acute hemolysis solely from back pain. Accurate product and patient identification must be available through the required process. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
20. Case 2: preserve the clinical and product timeline
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 20 / 55 RN Clarity Case 2: preserve the clinical and product timeline 01 Reassess symptoms, vital signs and prescribed investigations. 02 Follow instructions for the product, tubing and specimens. 03 Record the event and any authorized subsequent transfusion plan. Sources: BLOOD · Details and public links in notes
Teaching explanation
A reaction investigation needs accurate timing and traceable product information. Local procedures govern exactly which items are sent and who reports the event. A restart or future component modification decision belongs to the responsible clinical and transfusion team, not an assumption that the symptoms have settled. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
21. A flare and infection can look similar
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 21 / 55 RN Clarity A flare and infection can look similar 01 Autoimmune disease can cause fever, fatigue and organ symptoms. 02 Immunosuppressive treatment can increase infection vulnerability. 03 A new symptom deserves assessment rather than an automatic flare label. Sources: LUPUS • THERAPY · Details and public links in notes
Teaching explanation
Lupus is one example of systemic autoimmune disease. Disease activity, infection and treatment adverse effects may produce overlapping symptoms. The nurse should gather current observations and medication history and communicate concern. Do not independently increase immune therapy because a symptom resembles a previous flare. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
22. Assess beyond the known diagnosis
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 22 / 55 RN Clarity Assess beyond the known diagnosis 01 Identify immediate breathing, circulation or neurologic threats. 02 Compare symptoms and organ-function findings with baseline. 03 Seek the appropriate assessment before changing immune treatment. Sources: LUPUS • THERAPY · Details and public links in notes
Teaching explanation
The presence of a chronic diagnosis can create anchoring: every new finding is attributed to that diagnosis. Counter this by asking what else could explain the change and what would be dangerous to miss. The team determines the diagnostic and treatment plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
23. Connect immune therapy with surveillance
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 23 / 55 RN Clarity Connect immune therapy with surveillance 01 Corticosteroids reduce inflammation but have important risks. 02 Other immune medicines need drug-specific monitoring. 03 Report infection symptoms and adverse effects promptly.
Teaching explanation
Monitoring depends on the medicine, dose, duration and patient. Do not abruptly stop or alter a long-term corticosteroid regimen without the appropriate plan. A pharmacist or prescriber can clarify interactions, missed-dose instructions and laboratory monitoring. Avoid presenting all immunosuppressants as interchangeable. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
24. Case 3: “It is probably my usual flare”
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 24 / 55 RN Clarity Case 3: “It is probably my usual flare” FICTIONAL BEDSIDE SCENARIO 01 Elena has lupus and takes immune-modifying treatment. 02 She develops fever, a new cough and unusual fatigue. 03 She asks whether to increase her steroid dose as she once did before. Sources: LUPUS • THERAPY · Details and public links in notes
Teaching explanation
Fictional case. New cough and fever need assessment for infection and other causes. A past treatment decision is not a standing instruction for the present illness. Ask learners how they would validate the concern, assess stability and obtain a current plan without dismissing the patient’s experience. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
25. Case 3: keep more than one explanation open
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 25 / 55 RN Clarity Case 3: keep more than one explanation open “She has lupus, but these respiratory symptoms are new.” “We need to assess infection as well as disease activity.” “Please clarify the treatment plan before any dose change.” Sources: LUPUS • TEAM · Details and public links in notes
Teaching explanation
The wording respects the patient’s knowledge while preventing an unsupported treatment change. State the actual immune medicines and relevant observations. If the patient is unstable, use the emergency route rather than waiting for routine specialty advice. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
26. Case 3: follow the evidence as it develops
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 26 / 55 RN Clarity Case 3: follow the evidence as it develops 01 Track symptoms, ordered results and organ function. 02 Reconcile the current medication instructions. 03 Explain what the patient should report while the plan evolves. Sources: THERAPY • TEAM · Details and public links in notes
Teaching explanation
A change in diagnosis or treatment should be communicated clearly to the patient and receiving staff. Check understanding of which medicines continue, change or need clarification. Record the current plan rather than carrying forward an earlier assumption about a flare. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
27. Low neutrophils increase infection risk
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 27 / 55 RN Clarity Low neutrophils increase infection risk 01 Neutrophils help defend against infection. 02 Cancer treatment can lower the count. 03 A patient may need urgent assessment for a new fever or illness. Sources: NCI · Details and public links in notes
Teaching explanation
Neutropenia is a reduction in neutrophils, not a diagnosis of infection. Risk depends on the degree and duration of suppression and the clinical context. The treatment team provides a specific fever and contact plan. Do not delay because the patient’s skin or a line site lacks dramatic inflammation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
28. Suspected infection needs prompt escalation
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 28 / 55 RN Clarity Suspected infection needs prompt escalation 01 Assess current symptoms and signs of instability. 02 Contact the oncology or urgent-care pathway without delay. 03 Support prescribed investigations and timely treatment. Sources: NCI · Details and public links in notes
Teaching explanation
A febrile or unwell patient with known or possible neutropenia requires prompt evaluation. The local pathway sets fever criteria, investigation and antimicrobial timing. Do not wait for all laboratory results before communicating the concern. Avoid treating fever at home in a way that postpones contact with the care team. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
29. Prevention is practical and patient-specific
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 29 / 55 RN Clarity Prevention is practical and patient-specific 01 Use hand hygiene and the prescribed device-care plan. 02 Report new mouth, skin, respiratory or urinary symptoms. 03 Follow individualized food, exposure and vaccination advice.
Teaching explanation
Do not invent a universal neutropenic diet or isolation rule. Prevention advice depends on treatment and local guidance. Ask what the patient can realistically do at home and clarify uncertainty with the oncology team. Teach the contact plan before the period of increased risk. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
30. Case 4: the patient feels well enough to wait
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 30 / 55 RN Clarity Case 4: the patient feels well enough to wait FICTIONAL BEDSIDE SCENARIO 01 After chemotherapy, Ben reports fever and shaking chills. 02 He knows his neutrophil count was recently low. 03 He plans to take an antipyretic and call the clinic tomorrow. Sources: NCI · Details and public links in notes
Teaching explanation
Fictional case. The concern is possible infection during neutropenia. The learner should direct prompt assessment through the patient’s emergency or oncology plan, not endorse waiting overnight. If severe symptoms are present, emergency services are appropriate. Medication advice must not replace urgent contact. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
31. Case 4: state the immune-risk context
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 31 / 55 RN Clarity Case 4: state the immune-risk context “He has fever and rigors after recent chemotherapy.” “A low neutrophil count was reported recently.” “He needs prompt assessment through the oncology emergency plan.” Sources: NCI • TEAM · Details and public links in notes
Teaching explanation
Use the known result and date if available; otherwise say what is reported and by whom. The patient’s apparent comfort does not remove the need for evaluation. Ask the receiving learner to identify the time-sensitive concern and the next step. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
32. Case 4: continue after the first treatment
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 32 / 55 RN Clarity Case 4: continue after the first treatment 01 Reassess symptoms, perfusion and prescribed observations. 02 Track cultures, blood counts and treatment response as ordered. 03 Hand over pending results and the escalation contingency. Sources: NCI • TEAM · Details and public links in notes
Teaching explanation
Giving the first treatment does not complete the nursing response. Ongoing assessment helps detect deterioration or lack of response. The team needs clear ownership of pending results and subsequent therapy. Teach learners to record changes rather than simply marking an antibiotic task complete. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
33. A transplant balances rejection and infection risk
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 33 / 55 RN Clarity A transplant balances rejection and infection risk 01 The immune system may recognize the graft as foreign. 02 Anti-rejection medicines reduce that immune response. 03 The same treatment can increase infection and other risks. Sources: TX · Details and public links in notes
Teaching explanation
Kidney transplantation is the example used here. Anti-rejection treatment helps preserve graft function but requires ongoing follow-up and monitoring. The balance is individualized; more or less immunosuppression is not automatically better. Other transplanted organs require their own specialist surveillance. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
34. New graft dysfunction needs review
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 34 / 55 RN Clarity New graft dysfunction needs review 01 Compare symptoms and organ-function trends with baseline. 02 Review medicine access, recent doses and intercurrent illness. 03 Contact the transplant team for the current assessment plan. Sources: TX · Details and public links in notes
Teaching explanation
A change in kidney function may reflect rejection, infection, dehydration, obstruction, medicine toxicity or another cause. Do not diagnose rejection from one value alone. The nurse supplies an accurate history and observations while the transplant team determines investigations and treatment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
35. Protect the medication plan at transitions
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 35 / 55 RN Clarity Protect the medication plan at transitions 01 Verify the exact anti-rejection regimen and formulation. 02 Clarify missed or vomited doses with the transplant team. 03 Check interactions before adding nonprescription products.
Teaching explanation
Some immunosuppressant regimens require carefully timed blood sampling relative to doses. Use the exact ordered timing rather than guessing. A missed dose should not lead to an improvised double dose. Medication reconciliation is especially important during emergency admission or transfer to a nonspecialist ward. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
36. Case 5: a medicine supply problem is hidden
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 36 / 55 RN Clarity Case 5: a medicine supply problem is hidden FICTIONAL BEDSIDE SCENARIO 01 A kidney-transplant recipient has missed several doses. 02 She was unable to collect a refill and felt embarrassed to tell staff. 03 Her follow-up test shows a change from her usual kidney function. Sources: TX · Details and public links in notes
Teaching explanation
Fictional case. The correct response is prompt transplant-team assessment and an accurate medication history, not blame or an automatic rejection diagnosis. Explore the access barrier and support a sustainable supply plan. Do not independently compensate for missed doses. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
37. Case 5: make the barrier clinically visible
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 37 / 55 RN Clarity Case 5: make the barrier clinically visible “She missed doses because she could not obtain the refill.” “Her kidney-function result has changed from baseline.” “We need transplant-team advice and a reliable medication supply plan.” Sources: TX • TEAM · Details and public links in notes
Teaching explanation
A respectful account improves the chance that the patient will disclose future difficulties. Name the actual medicine, missed-dose history and result when verified. The care team determines how to restore treatment and assess the graft; the nurse helps make the plan understandable and feasible. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
38. Case 5: confirm the plan can be followed
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 38 / 55 RN Clarity Case 5: confirm the plan can be followed 01 Reconcile the final regimen with the patient and pharmacy. 02 Confirm laboratory timing and follow-up instructions. 03 Use teach-back to check the missed-dose and illness contact plan. Sources: TX • TEAM · Details and public links in notes
Teaching explanation
A prescription alone does not resolve an access problem. Confirm how the patient will obtain the medicine and whom they can contact if another problem occurs. The transplant team’s instructions should be specific enough that the patient does not need to improvise during illness. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
39. Worked case: an infusion and a rapid change
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 39 / 55 RN Clarity Worked case: an infusion and a rapid change Fictional observations • during a new infusion Observation Before Now Voice Usual New hoarseness Breathing Comfortable Difficult Skin findings No rash Still no rash Which change needs immediate emergency assessment? Sources: ANA · Details and public links in notes
Teaching explanation
The table teaches a clinical pattern, not a diagnostic threshold. A voice change and circulatory deterioration during an exposure require urgent assessment. Absence of rash does not exclude anaphylaxis. The team determines treatment through the current emergency pathway. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
40. The airway change matters without a rash
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 40 / 55 RN Clarity The airway change matters without a rash New voice and breathing changes are urgent cues. Activate help and support the authorized emergency response. Do not wait for hives to appear before acting. Sources: ANA · Details and public links in notes
Teaching explanation
Ask learners to explain what could be dangerous to miss. This is a recognition exercise, not proof of the allergen. The immediate response addresses the threat while clinicians consider alternative causes and determine the treatment plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
41. NGN-style exercise: select the appropriate actions
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 41 / 55 RN Clarity NGN-style exercise: select the appropriate actions CHOOSE • EXPLAIN YOUR REASONING 01 A: Escalate the new airway and breathing problem immediately. 02 B: Wait for a skin rash before activating the response. 03 C: Report the infusion, symptom timing and current observations. Sources: ANA · Details and public links in notes
Teaching explanation
Original multiple-response practice exercise, not an official NCLEX-RN® item. A and C are appropriate. B delays care based on a false requirement for a rash. Have learners explain the rationale in plain language before discussing the specific local emergency pathway. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
42. Answer: respond to the clinical threat
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 42 / 55 RN Clarity Answer: respond to the clinical threat 01 A and C address urgency and relevant exposure information. 02 B overlooks a potentially severe reaction without skin signs. 03 Reassess after treatment and communicate any recurrence. Sources: ANA • TEAM · Details and public links in notes
Teaching explanation
A correct answer includes both action and explanation. Ask students to state what they would assess next and what information they would give the response team. Avoid scoring a particular institution’s phone number, documentation sequence or device workflow as universal knowledge. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
43. Make immune medicines understandable
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 43 / 55 RN Clarity Make immune medicines understandable 01 Explain the reason for each prescribed medicine. 02 Link it with the specific monitoring and safety advice. 03 Clarify a new symptom rather than changing the regimen alone. Sources: THERAPY • TX · Details and public links in notes
Teaching explanation
The patient needs to understand both benefit and risk. Treatment changes should come from the appropriate clinician, particularly with corticosteroids and transplant medicines. Use current product-specific information for doses, interactions and missed-dose advice rather than a general immune-system summary. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
44. Use the right words for a reaction
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 44 / 55 RN Clarity Use the right words for a reaction 01 Adverse effect = an unwanted treatment effect. 02 Allergy = an immune-mediated reaction to a substance. 03 Intolerance = difficulty tolerating a substance, not necessarily allergy.
Teaching explanation
These terms help communication but do not let a learner reclassify a patient’s record without assessment. Record what happened, the time course and what remains uncertain. Allergy evaluation can clarify future treatment choices; an emergency reaction should be treated promptly while that longer-term work remains pending. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
45. A useful handoff separates fact from suspicion
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 45 / 55 RN Clarity A useful handoff separates fact from suspicion 01 What exposure, treatment or immune risk is confirmed? 02 What changed, and what action has been taken? 03 Which result, review or reassessment remains pending? Sources: TEAM · Details and public links in notes
Teaching explanation
Use precise language such as “possible reaction” or “reported missed doses” when appropriate. A receiving clinician should not mistake a working concern for a confirmed diagnosis. Closed-loop handoff helps ensure that the unresolved issue has an owner. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
46. Teach a plan the patient can use at home
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 46 / 55 RN Clarity Teach a plan the patient can use at home 01 Confirm the rescue or urgent-contact instructions. 02 Check medicine access and the follow-up schedule. 03 Ask the patient to explain what they will do if symptoms recur. Sources: ALL • NCI • TX • TEAM · Details and public links in notes
Teaching explanation
Use the actual individualized plan. Community rescue devices, oncology contact pathways and transplant instructions differ. Teaching should make the next step clear without overwhelming the patient with every possible complication. Arrange interpretation or accessible materials when needed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
47. Respect the patient’s expertise and concerns
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 47 / 55 RN Clarity Respect the patient’s expertise and concerns “Tell me what is different from your usual symptoms.” “What has made the treatment difficult to follow?” “Let us confirm a plan that you can use safely.” Sources: TEAM · Details and public links in notes
Teaching explanation
Patients often know subtle changes in their own condition. Listening does not mean accepting every self-diagnosis as confirmed. Combine the patient’s account with assessment and evidence, and explore practical barriers without blame. This supports accurate information and shared planning. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
48. Avoid three immune-care reasoning traps
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 48 / 55 RN Clarity Avoid three immune-care reasoning traps 01 No rash does not mean no anaphylaxis. 02 A known autoimmune disease does not explain every fever. 03 A graft-function change does not prove rejection by itself. Sources: ANA • THERAPY • TX · Details and public links in notes
Teaching explanation
Each statement counters a specific oversimplification from the cases. Ask learners what additional information or action is needed in each situation. The goal is disciplined uncertainty: take the threat seriously while keeping the diagnostic reasoning open. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
49. Learn the local response routes before practice
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 49 / 55 RN Clarity Learn the local response routes before practice 01 Locate anaphylaxis and transfusion reaction resources. 02 Learn oncology and transplant escalation contacts. 03 Confirm treatment authority, monitoring and reporting procedures. Sources: ANA • BLOOD • TEAM · Details and public links in notes
Teaching explanation
Emergency Care BC is emergency-department guidance from British Columbia, and Canadian Blood Services has a defined Canadian context. Neither establishes one national RN scope rule. Use local clinical protocols and professional requirements to apply the lesson in a specific USA or Canadian setting. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
50. Teacher debrief: connect mechanism with action
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 50 / 55 RN Clarity Teacher debrief: connect mechanism with action Which mechanism explains the important cues? What tempting assumption could delay the response? What will you reassess to judge whether the plan helped?
Teaching explanation
Run a paired simulation: one learner assesses and reports; the other identifies the next step and repeats the plan. Introduce a new cue before the scenario ends. Debrief both the clinical reasoning and the clarity of the communication, including how uncertainty was expressed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
51. Evidence guide: immunity and reactions
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 51 / 55 RN Clarity Evidence guide: immunity and reactions NIAID • Overview of the Immune System NIAID • Features of an Immune Response Emergency Care BC • Anaphylaxis: Diagnosis & Treatment AAAAI • Anaphylaxis Canadian Blood Services • Transfusion reactions Sources: IMM • RESP • ANA • ALL • BLOOD · Details and public links in notes
Teaching explanation
The sources serve different purposes: immune-system explanation, emergency treatment, patient preparedness and transfusion reaction assessment. The linked locators identify the relevant topics. No proprietary algorithm or dosing table is reproduced. Current local emergency resources remain necessary. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAID • Overview of the Immune System
- Locator: Immune function; February 2026
- https://www.niaid.nih.gov/research/immune-system-overview
- NIAID • Features of an Immune Response
- Locator: Innate and adaptive responses
- https://www.niaid.nih.gov/research/immune-response-features
- Emergency Care BC • Anaphylaxis: Diagnosis & Treatment
- Locator: Recognition and initial emergency treatment; emergency-department context
- https://emergencycarebc.ca/clinical_resource/clinical-summary/anaphylaxis-diagnosis-treatment/
- AAAAI • Anaphylaxis
- Locator: Symptoms, emergency preparedness and epinephrine
- https://www.aaaai.org/conditions-treatments/allergies/anaphylaxis
- Canadian Blood Services • Transfusion reactions
- Locator: Clinical Guide, chapter 10; fever, dyspnea and acute hemolysis
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
52. Evidence guide: therapy and transplant
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 52 / 55 RN Clarity Evidence guide: therapy and transplant NIAMS • Lupus NIAMS • Lupus: Diagnosis, Treatment and Steps to Take NCI • Infection and Neutropenia during Cancer Treatment NIDDK • Kidney Transplant The transplant example is kidney-specific, not a protocol for every organ. Sources: LUPUS • THERAPY • NCI • TX · Details and public links in notes
Teaching explanation
The clinical explanation distinguishes disease activity, infection risk and medicine effects. Publication dates are retained honestly. The cases illustrate reasoning and do not claim to establish diagnostic criteria or a treatment plan for an actual person. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NIAMS • Lupus
- Locator: Symptoms and systemic involvement
- https://www.niams.nih.gov/health-topics/lupus
- NIAMS • Lupus: Diagnosis, Treatment and Steps to Take
- Locator: Treatment, monitoring and self-management
- https://www.niams.nih.gov/health-topics/lupus/diagnosis-treatment-and-steps-to-take
- NCI • Infection and Neutropenia during Cancer Treatment
- Locator: Infection symptoms and when to seek care
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- NIDDK • Kidney Transplant
- Locator: Anti-rejection medicines, complications and follow-up; kidney-transplant example
- https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/kidney-transplant
53. Evidence guide: teaching and communication
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 53 / 55 RN Clarity Evidence guide: teaching and communication AHRQ • TeamSTEPPS tools Original fictional cases and original practice questions. Public source links and locators are embedded in notes. Use the source population and setting when applying recommendations. Use current local policies for clinical implementation. Sources: TEAM · Details and public links in notes
Teaching explanation
This material supports teaching and supervised clinical preparation. It is not an official examination product, an order set or a guarantee of complete coverage. Teachers can use the speaker notes for case rationale and discussion while applying current institutional guidance to practice. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
54. Make uncertainty and the next step clear
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 54 / 55 RN Clarity Make uncertainty and the next step clear Recognize the change and the patient’s immune-risk context. Explain the threat without claiming an unconfirmed diagnosis. Confirm the plan, reassess and close the handoff loop.
Teaching explanation
End with one case in which learners must explain both what they know and what they do not yet know. Safe action does not require certainty about every cause. It requires recognizing time-sensitive threats, communicating accurately and supporting the appropriate assessment and response. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
55. Make the next action clear
Slide text
RN Clarity C03 / CLINICAL SYSTEMS RN Clarity • Learning for practice 55 / 55 RN Clarity Make the next action clear Notice the reaction. Recognize the risk. Reassess the response. RN Clarity • rnclarity.com Independent preparation for the NCLEX-RN® examination. NCLEX-RN® is an NCSBN trademark. RN Clarity is independent and not endorsed by NCSBN.
Teaching explanation
NCLEX® and NCLEX-RN® are registered trademarks of NCSBN. RN Clarity is independent and is not affiliated with, sponsored by or endorsed by NCSBN. This presentation is educational preparation, not a clinical order set. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
Supports learning and orientation. Follow current local policies and scope of practice.